Parvovirus B19
Nucleic Acid Test
Kit Market, Global Outlook and Forecast 2022-
2028 Market
Human Parvovirus B19 Nucleic Acid Test Kit Market, Global Outlook and Forecast 2022-2028 Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Human Parvovirus B19 Nucleic Acid Test Kit Market, Global Outlook and Forecast 2022-2028 Market Size and Growth
The Human Parvovirus B19 Nucleic Acid Test Kit Market is projected to experience significant growth from 2022 to 2028, driven by an increasing prevalence of parvovirus infections worldwide. The market size is estimated to reach USD XX million by the end of 2028, with a CAGR of XX% during the forecast period.
Request Sample Report
Companies Covered
(Covid
19 Impact Covered)
◍ BioGerm(Shanghai Berger Medical Technology Company)
◍ Xiamen Amplly Co., Ltd.
◍ Innodx
◍ Jinan Kinghawk Technology Co.,Ltd.
◍ Liferiver Bio-Tech
The Human Parvovirus B19 Nucleic Acid Test Kit Market is highly competitive with key players like BioGerm, Xiamen Amplly, Innodx, and others dominating the market. These companies leverage innovative technology and strategic partnerships to drive growth in the market. Sales revenue figures include BioGerm: $10 million, Xiamen Amplly: $8 million, Innodx: $5 million.
◍ Jiangsu Bioperfectus Technologies Co., Ltd.
◍ Norgen Biotek Corp.
◍ ELITechGroup
◍ Diagnostic Technology
◍ altona Diagnostics GmbH
◍ bioMérieux
◍ bioneovan co., ltd.
Request Sample Report
